Scientists at biotech and pharma companies depend on a wide range of peer-reviewed literature to do their jobs. And there's a LOT to choose from. Consider these stats from the International Association of Scientific, Technical and Medical Publishers
- 10,000+ journal publishers globally
- 42,500+ active scholarly peer-reviewed journals in mid-2018, increasing by 5% year over year
- 3M+ articles published annually, increasing by 4% year over year
- Researchers read an average of 250 articles per year, depending on discipline
This wealth of published content, however, is not always equally accessible to all researchers. For small- and medium-sized enterprises (SMEs) in particular, obtaining the articles they need may require a larger R&D budget and more resources than they have.
And that leads to tough decisions.
With so many valuable scientific publications, how do you prioritize your purchases? How do you choose when a subscription makes the most sense—and when it will be more cost-efficient to access articles individually? Oftentimes, these decisions are based largely on guesswork. But even when prioritization strategies are data driven—and despite the recent push toward Open Access—most biotech companies still struggle to minimize per-article spend and maximize the value of their holdings.
That’s where Article Galaxy+ brings welcome relief.
Made possible through a pilot program with Springer Nature, Article Galaxy+ is a specially packaged offering available exclusively to organizations with fewer than 100 R&D staff. In addition to all the features our platform is known for (e.g. one-click access to 70K+ articles from all major publishers, lowest-cost acquisition filters, automated compliance), Article Galaxy+ gives SMEs limitless, pre-loaded access to Springer Nature’s entire collection of journals and ebooks.
The Springer Nature collection accounts for approximately 35% of the world's scientific literature, including more than 2,500 Springer journals, 100 Nature-branded and academic journals, and 250,000 Springer ebooks. Article Galaxy+ provides preloaded access to the entire collection for 12 months, after which time customers have the option to purchase collections tailored to their needs.
In partnership with Springer Nature, we are committed to giving researchers and scientists the opportunity to deliver successful, commercial research initiatives—with fast, affordable access to the most influential content collections.
Tag(s):
BioTech/Pharma
Lettie Y. Conrad | Product & Publishing Consultant
Lettie brings nearly 20 years’ experience in scholarly publishing to her diverse portfolio of product research and development projects. She is dedicated to helping information organizations cultivate a user-centered, standards-compliant approach to digital publishing and academic programs. Her expertise lies in...
Popular at Research Solutions
View All ArticlesSubscribe to email updates
Stay up-to-date on what's happening at this blog and get additional content about the benefits of subscribing.